JP2015520223A - 炎症性疾患の局所処置に使用するため脱水した鶏卵卵白を含む組成物 - Google Patents

炎症性疾患の局所処置に使用するため脱水した鶏卵卵白を含む組成物 Download PDF

Info

Publication number
JP2015520223A
JP2015520223A JP2015517910A JP2015517910A JP2015520223A JP 2015520223 A JP2015520223 A JP 2015520223A JP 2015517910 A JP2015517910 A JP 2015517910A JP 2015517910 A JP2015517910 A JP 2015517910A JP 2015520223 A JP2015520223 A JP 2015520223A
Authority
JP
Japan
Prior art keywords
treatment
inflammatory
composition according
formulation
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015517910A
Other languages
English (en)
Japanese (ja)
Inventor
カルロ・テルッツィ
ルカ・デグラッシ
Original Assignee
ギエレッピ・ソチエタ・ペル・アツィオーニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ギエレッピ・ソチエタ・ペル・アツィオーニ filed Critical ギエレッピ・ソチエタ・ペル・アツィオーニ
Publication of JP2015520223A publication Critical patent/JP2015520223A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
JP2015517910A 2012-06-20 2013-06-20 炎症性疾患の局所処置に使用するため脱水した鶏卵卵白を含む組成物 Pending JP2015520223A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2012A001076 2012-06-20
IT001076A ITMI20121076A1 (it) 2012-06-20 2012-06-20 Composizione per uso locale nel trattamento del danno tissutale
PCT/IB2013/055066 WO2013190496A2 (en) 2012-06-20 2013-06-20 Composition and formulation for topical treatment of inflammation and tissue damage

Publications (1)

Publication Number Publication Date
JP2015520223A true JP2015520223A (ja) 2015-07-16

Family

ID=46466706

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517910A Pending JP2015520223A (ja) 2012-06-20 2013-06-20 炎症性疾患の局所処置に使用するため脱水した鶏卵卵白を含む組成物

Country Status (8)

Country Link
US (1) US20150320838A1 (enExample)
EP (1) EP2863928A2 (enExample)
JP (1) JP2015520223A (enExample)
CN (1) CN104640552A (enExample)
IN (1) IN2015KN00091A (enExample)
IT (1) ITMI20121076A1 (enExample)
RU (1) RU2015101485A (enExample)
WO (1) WO2013190496A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180080142A (ko) * 2017-01-03 2018-07-11 서울대학교산학협력단 소 유방염 치료제 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003128557A (ja) * 2001-10-16 2003-05-08 Teikoku Seiyaku Co Ltd グルコサミン含有パップ剤
JP2003525868A (ja) * 1999-09-14 2003-09-02 ディーシーヴィー インコーポレイテッド 炎症を低減させるグルコサミンおよび卵
JP2004067562A (ja) * 2002-08-05 2004-03-04 Rohto Pharmaceut Co Ltd 外用組成物
JP2010506908A (ja) * 2006-10-20 2010-03-04 スーヨル キム， グルコサミンまたはグルコサミン誘導体を含むアトピー性皮膚炎治療用組成物およびこれらを使用しアトピー性皮膚炎を治療する方法
JP2010070493A (ja) * 2008-09-18 2010-04-02 Kagoshima Univ 抗菌剤およびその製造方法、化粧料ならびに医薬品

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
CN1178671C (zh) 1996-03-26 2004-12-08 Dcv公司 蛋抗炎成分、分离方法和用途
AU2372400A (en) * 1999-01-19 2000-08-07 Dcv, Inc. Egg anti-inflammatory composition and method of treating and preventing inflammation
US6706267B1 (en) * 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
AU2001260794A1 (en) * 2000-05-23 2001-12-03 N.V. Nutricia Use of egg white and egg white fractions for tissue regeneration
FR2810550B1 (fr) 2000-06-27 2004-10-08 Medibrevex Nouvelle formes galeiques solubles d'oeufs de caille a usage medicamenteux pour lavage oculaire et nasale et leurs procedes de fabrication
RU2191551C1 (ru) 2001-07-05 2002-10-27 Волков Александр Григорьевич Способ лечения неосложненных фронтитов
US20030125303A1 (en) * 2001-12-28 2003-07-03 Andrew Kucharchuk Transdermal formulation for repair and maintenance of connective tissue
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
US20050053564A1 (en) * 2003-09-04 2005-03-10 Chaim Lieberman Use a plant extract to enhance hair growth and hair restoration for damaged hair
US20060029657A1 (en) * 2004-03-26 2006-02-09 Stiefel Laboratories, Inc. Topical skin protectant compositions
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525868A (ja) * 1999-09-14 2003-09-02 ディーシーヴィー インコーポレイテッド 炎症を低減させるグルコサミンおよび卵
JP2003128557A (ja) * 2001-10-16 2003-05-08 Teikoku Seiyaku Co Ltd グルコサミン含有パップ剤
JP2004067562A (ja) * 2002-08-05 2004-03-04 Rohto Pharmaceut Co Ltd 外用組成物
JP2010506908A (ja) * 2006-10-20 2010-03-04 スーヨル キム， グルコサミンまたはグルコサミン誘導体を含むアトピー性皮膚炎治療用組成物およびこれらを使用しアトピー性皮膚炎を治療する方法
JP2010070493A (ja) * 2008-09-18 2010-04-02 Kagoshima Univ 抗菌剤およびその製造方法、化粧料ならびに医薬品

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180080142A (ko) * 2017-01-03 2018-07-11 서울대학교산학협력단 소 유방염 치료제 조성물
KR101979358B1 (ko) 2017-01-03 2019-05-15 서울대학교산학협력단 소 유방염 치료제 조성물

Also Published As

Publication number Publication date
US20150320838A1 (en) 2015-11-12
WO2013190496A2 (en) 2013-12-27
RU2015101485A (ru) 2016-08-10
WO2013190496A3 (en) 2014-02-27
ITMI20121076A1 (it) 2013-12-21
EP2863928A2 (en) 2015-04-29
CN104640552A (zh) 2015-05-20
IN2015KN00091A (enExample) 2015-07-31

Similar Documents

Publication Publication Date Title
JP5646446B2 (ja) 医療用化合物あるいは医療用製品を作成するための生体適合性ポリマーの使用方法
JP2024144774A (ja) 化粧品／皮膚科用組成物
CN108498593A (zh) 一种治疗颈肩腰腿痛的中药组合物
RU2433844C1 (ru) Способ лечения дегенеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических болевых синдромов
CN102441023B (zh) 一种治疗骨科疾病的注射用组合物
JP2015520223A (ja) 炎症性疾患の局所処置に使用するため脱水した鶏卵卵白を含む組成物
KR20150131864A (ko) 어류의 정액 또는 정소로부터 분리된 디엔에이 단편 혼합물을 함유하는 회전근개 파열의 예방 또는 치료용 약학 조성물
US11564958B2 (en) Compositions and methods of treatment of Ehlers-Danlos syndromes
JP2014530223A (ja) 再生性、鎮痛性および／または抗炎症性を有する卵調製物
Singh et al. An Ayurveda approach in the management of avascular necrosis of bilateral hip joint-A case report
CN109641001A (zh) 用于治疗缺血性溃疡和伸展疤痕的组合物
Campisi et al. Inclusion of targeted skin products in the pre-surgical treatment regimen of peripheral lymphedema & lipedema
JP3652865B2 (ja) 乳酸縮合物の混合物及びそれを含有する組成物
JP2018531228A (ja) 軟組織外傷からの回復を増強するためのβ−ヒドロキシ−β−メチルブチレート（ＨＭＢ）の組成物および使用方法
JP2018531228A6 (ja) 軟組織外傷からの回復を増強するためのβ−ヒドロキシ−β−メチルブチレート（ＨＭＢ）の組成物および使用方法
US20190365735A1 (en) Compositions and methods for treating varicose veins
RU2797341C1 (ru) Способ удаления кальцинатов у детей с ювенильным дерматомиозитом
Suhih et al. Perspective natural sources of chondroprotectors
Vladimirova et al. Excesive Scar Formation After Surgical Operations And Injuries: Expirience of Early Diagnosis and Prophyilaxis
Carolino et al. Latissimus dorsi muscle for functional reconstruction surgery of the triceps surae following soft tissue sarcoma resection
WO2024073011A1 (en) Topical compositions and methods for the treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
WO2024073013A1 (en) Combination treatment of dermal and transdermal fibrotic diseases, disorders and associated pain and inflammation
RU2324496C1 (ru) Способ лечения заболеваний, вызванных патологическим изменением хрящевой и/или костной ткани
RU2436584C1 (ru) Способ лечения дегеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических спаечных процессов
Fabbro et al. One year outcome of ultrasound (US)-guided percutaneous treatment of Achilles tendinopathy: results of a randomized controlled trial

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160523

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170905

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171101

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20171225